In Depth 22 Jul 2022
The coming of age story of RNAi technology
The first RNA interference (RNAi) therapy was approved in 2018, after 20 years in development. What can we expect to see in the RNAi field in the future? After two…
About
Farhan is a science communicator based in the UK with a background in the biotech sector. He is currently studying for a masters degree in Evolutionary Genomics. Find him on twitter – @FarhanMitha
Articles by Farhan Mitha
In Depth 9 May 2022
Exosome Therapy: Borrowing from Nature’s Toolbox
In just a few years, exosomes have started gaining recognition as a solution to deliver treatments safely and effectively, and as a new approach to regenerative medicine. For hundreds of…
In Depth 18 Jan 2022
Biomining: Turning Waste into Gold with Microbes
High-value metals make the modern world go round, but the way we extract and dispose of them is far from sustainable. Biomining could be an elegant and lucrative alternative. From…
In Depth 14 Jun 2021
Biomimicry in Biotech: Taking Inspiration from Nature
Scouring the natural world can be an effective way of finding design inspiration for new scientific innovation. Several biotech companies are using biomimicry to develop weird and wonderful bio-inspired products.…
ADVERTISEMENT
In Depth 1 Mar 2021
How Are European Biotechs Tackling the Cardiovascular Disease Problem?
Cardiovascular diseases may not regularly grab the headlines, but they’re the leading cause of mortality globally, making up over 30% of all deaths worldwide. While there are many established treatments…
In Depth 21 Dec 2020
Enemy or Valuable Ally? How Biotech Uses Viruses for Good
Taking advantage of the ability of viruses to manipulate life is opening new doors for the biotech industry. Once only seen as our enemies, viruses are fast becoming some of…
ADVERTISEMENT
In Depth 4 Nov 2020
The Return of Gene Therapy
Gene therapy is a hot area in the biotech industry right now, with many treatments in development and a number of recent approvals. However, the path has not always been…
Interview 2 Sep 2020
An Alzheimer’s Vaccine Challenged the Consensus for 25 Years
For decades, Alzheimer's disease research focused on a hypothesis that has increasingly been contested. A team of scientists in Slovakia has been swimming against the tide since the beginning, going…
In Depth 12 Aug 2020
Life at its Limits: The Biotech Industry Embraces Extremophiles
Sometimes in biotech, when your standard E. coli just won't cut it, something more exotic is needed. Could extremophiles be the answer? Given enough time, and the right mutations, life…
In Depth 22 Jun 2020
The Age of Agrochemicals is Ending: It’s Time for Agricultural Biotechnology
As Europe moves to reduce its reliance on agrochemicals in the farming system over the next 10 years and beyond, a crucial question emerges: what replaces them? Agricultural biotechnology could…
In Depth 18 Mar 2019
The Search for a Better Biofuel: Can Biotech Deliver?
With dire climate change reports landing one after another in 2018 the need for sustainable, scalable, and affordable biofuels to aid in this transition to a more sustainable future has…
In Depth 25 Jul 2018
Could These Groundbreaking Therapies Make Conventional Antibiotics a Thing of the Past?
With the rise of antimicrobial resistance across the globe, and with a dire lack of new antibiotics in the pipeline, more attention is going towards developing innovative treatments and technologies…